Is it always necessary to perform an axillary lymph node dissection after neoadjuvant chemotherapy for breast cancer?

CONCLUSIONS: This model could be a helpful tool for the surgeon to help in predicting which cases have a higher likelihood of achieving a pathologically complete response and therefore selecting those who may benefit from a post-neoadjuvant chemotherapy sentinel lymph node biopsy and avoid unnecessary axillary lymphadenectomy. PMID: 30421628 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30421628?dopt=Abstract

Source: Annals of the Royal College of Surgeons of England - November 13, 2018 Category: Surgery Authors: Osorio-Silla I, Gómez Valdazo A, Sánchez Méndez JI, York E, Díaz-Almirón M, Gómez Ramírez J, Rivas Fidalgo S, Oliver JM, Álvarez CM, Hardison D, Díaz Miguel M, Lobo F, Díaz Domínguez J Tags: Ann R Coll Surg Engl Source Type: research